What does Tatva Chintan do?

Jul 17 2025 07:43 AM IST
share
Share Via
Tatva Chintan Pharma Chem Ltd is a small-cap company in the specialty chemicals industry, incorporated in 1996 and publicly listed since January 2021, with recent net sales of ₹1,079 Cr and a net profit of ₹10 Cr as of March 2025. Key metrics include a P/E ratio of 388.00 and a market cap of ₹2,216 Cr.
Overview:
Tatva Chintan Pharma Chem Ltd operates in the specialty chemicals industry and is categorized as a small-cap company.

History:
The company was incorporated in 1996 as 'Tatva Chintan Pharma Chem Private Limited' and transitioned to a public limited company on 27 January 2021. The latest reported quarterly results indicate net sales and net profit for the period ending March 2025.

Financial Snapshot:
- Net Sales: 1,079 Cr (Quarterly Results - Mar 2025)
- Net Profit: 10 Cr (Quarterly Results - Mar 2025)
- Market Cap: INR 2,216 Cr (Small Cap)

Key Metrics:
- P/E: 388.00
- Industry P/E: 47
- Dividend Yield: 0.21%
- Debt-Equity: 0.03
- Return on Equity: 0.77%
- Price to Book: 2.97

Contact Details:
No Company Details Available. Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News